Hindustan Unilever Limited has informed the Exchange about Acquisition

Hindustan Unilever (HUL) has approved acquiring the remaining 49% stake in Zywie Ventures Private Limited (which runs the OZiva brand of vitamins, minerals, supplements, and protein products) for a cash consideration of Rs 824 crores. This will make Zywie and its subsidiary Zenherb Labs wholly owned subsidiaries of HUL. Zywie's turnover grew from Rs 100.07 crores in FY23 to Rs 257.67 crores in FY25, and the press release highlights OZiva scaling to about Rs 480 crores in 2025 with roughly 130% CAGR over the last two years. Separately, HUL's board has approved selling its 19.8% minority stake in Nutritionalab Private Limited (a joint venture with Rs 118.48 crores revenue in FY25) to USV Private Limited for Rs 307 crores. Both deals are expected to close by 31 March 2026, subject to closing conditions. The transactions align with HUL's stated strategy of 'fewer, bigger bets' in the fast-growing Health & Wellbeing category.